Back to Search Start Over

Pneumococcal vaccination in developing countries

Authors :
Levine, Orin S.
O'Brien, Katherine L.
Knoll, Maria
Adegbola, Richard A.
Black, Steven
Cherian, Thomas
Dagan, Ron
Goldblatt , David
Grange, Adenike
Greenwood, Brian
Hennessy, Tom
Klugman, Keith P.
Madhi, Shabir A.
Mulholland, E. Kim
Nohynek, Hanna
Santosham, M.
Saha, Samir K.
Scott, J. Anthony
Sow , Samba
Whitney, Cynthia G.
et al.
Levine, Orin S.
O'Brien, Katherine L.
Knoll, Maria
Adegbola, Richard A.
Black, Steven
Cherian, Thomas
Dagan, Ron
Goldblatt , David
Grange, Adenike
Greenwood, Brian
Hennessy, Tom
Klugman, Keith P.
Madhi, Shabir A.
Mulholland, E. Kim
Nohynek, Hanna
Santosham, M.
Saha, Samir K.
Scott, J. Anthony
Sow , Samba
Whitney, Cynthia G.
et al.
Publication Year :
2006

Abstract

WHO estimates that about 1·6 million people, including up to 1 million children under 5 years old, die every year of pneumococcal pneumonia, meningitis, and sepsis.1 In populations with high child-mortality rates, pneumonia is the leading infectious cause of mortality and accounts for about 20–25% of all child deaths.2 In these populations, Streptococcus pneumoniae is identified consistently as the leading cause of bacterial pneumonia, and pneumococcal bacteraemia is an important cause of child mortality. 3, 4 and 5 HIV infection increases risk for pneumococcal disease 20–40-fold, and antibiotic resistance makes treatment difficult and expensive. 6 Thus pneumococcal disease is a major global-health issue.

Details

Database :
OAIster
Publication Type :
Electronic Resource
Accession number :
edsoai.ocn892263244
Document Type :
Electronic Resource